Skip to main content

Revived Febit Biotech to Employ 50 by Year-End

NEW YORK, March 20 (GenomeWeb News) - Febit Biotech, the microarray manufacturer that got a second life last year, said today that it has gradually added employees and expects a headcount of 50 by the end of 2006.

 

The company said that sales of its Geniom DNA analysis instrument "were on budget already in the year of Febit's re-establishment."

 

As GenomeWeb News reported last May, Febit Biotech was created 19 months after Febit went out of business.

 

The company moved to a new facility in Heidelberg, Germany, and received an undisclosed investment from its original investors, Dietmar and Oliver Hopp.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.